National Pharmaceutical Congress (NPC) Podcast: Recent Episodes
Chronicle Companies
Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry.
healthbiz.substack.com
Associate Vice-President and GM of Incyte’s Chris White discusses Most Favoured Nation pricing impacts, drug access and reimbursement, and wildly authentic leadership.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Founder of Brighthive Innovation Group’s Leandra Wells discusses tech enablement, transforming organization on lean budgets, and prioritizing healthcare in Canada.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
CEO of Bloom Burton’s Brian Bloom discusses the themes of the 2025 Bloom Burton conference, return entrepreneurs in the Canadian Life Sciences landscape, and accelerating drug discovery with AI.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Canadian General Manager of argenx’s John Haslam discusses the big impact of rare disease, making key antibodies in the autoimmune space, and pricing strategy reform in Canada.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
CEO of Toboggan Labs’ Florencia Herra Vega discusses AI compliance and innovation, applying AI to the whole team instead of individually, and useful technology for quick solutions.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Country Manager of Merz Therapeutics’ Mike Stone discusses commercial launches, the speed of mid-sized pharma, and rebranding DEI.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Leverage’s Ian Howard discusses his time working in the public sector, treating illness versus promoting wellness, and the rise of cosmetic dermatology.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
National Director of Account Management of Sales of IQVIA’s Chris Hankey discusses biobanking, digital transformation, and better health outcomes for patients.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Director of Business Development of Bayshore Specialty Rx’s Shaminder Singh discusses patient support and care delivery, building adaptability and resilience into patient support programs, and the future of healthcare funding in Canada
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Head of Canadian Commercial Operations and Strategic Advisor of EMD Serono’s Khalid Sabihuddin discusses translating complex analytics into actionable guidance, international healthcare perspectives, and the healthcare policy climate.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Co-Chairman of BridgeBright Advisors’ Mike Cloutier discusses leadership at scale, leadership in the current political climate, and the hardware for being a successful leader.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Pangaea Consultants’ Managing Director Jeff Martens discusses going from an operating role to consulting, lack of access in today’s political climate, and doing less with more.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Seaford President Tamara Seales discusses navigating Canadian pharma regulations, team-building, and weaving DEI into the fabric of the company.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Mike Exton, CEO and Board Director of Lexicon Pharmaceuticals, talks about safeguards and limits for AI, smaller pharma veresus big pharma, and brand strategies based on data over belief.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Gordon McCauley, CEO of adMare BioInnovations, unpacks the profits, principles, and policies shaping today’s life sci industry.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Casey James Lawton, General Manager at Peirre Fabre Dermo-Cosmetic, talks about diverse career experiences, learning to pivot, and building strong, science-driven foundations.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Fatih Yetikardes, Country Manager of Daiichi Sankyo, gives insights into advancing patient care with company collaborations, the unique complexities of the Canadian healthcare system, and the ethical use and transparent governance of AI.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Dr. Bettina Hamelin, President of Innovative Medicines Canada, gives insights into the adoption of innovative technologies, domestic supply chain for pharmaceuticals, and excluding medicines as retaliatory measures for tariffs.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Paul Levesque, President and CEO of Theratechnologies Inc., gives insights into innovation in biopharma, the effects of tariffs on supply chain and pharma manufacturing, and cross-border business development.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Mark Nawacki, President and CEO of Searchlight Pharma, gives insights into starting a specialty pharma business, therapeutics for women’s health and migraine relief, and the shift to more personalized medicines in healthcare.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Lisa Mullett, Senior Vice-President of Sumitomo Pharma America, gives insights into the importance of diversity in companies and patient trials, stepping out of your comfort zone to further your career, and accelerating development with AI.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Tom Slowe, CEO of Breadcrumb Analytics, gives insights into using AI to sort and sift through statistics, the importance of context with data, and why AI should only be supplementary to human work.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Kenneth Custer, President and General Manager of Eli Lilly Canada, gives insights into his background in neuroscience, innovation in healthcare, and progress in therapeutics for obesity and Alzheimer’s.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Jonathan Soong, General Manager of Amicus Therapeutics, gives insights into being at the forefront of rare disease innovations, patient support programs, and the importance of real world evidence for rare diseases.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Rodrigo Reis, General Manager of UCB Pharma Canada, gives insights into fostering innovation in pharma, collaborating with UHN to expedite diagnoses, and entering the rare disease space with new innovative therapeutics.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Brian Bloom, CEO of Bloom Burton & Co., gives insights into changes in the Canadian Healthcare investment landscape, the return of the generalist investor, and the rise of consumer empowerment in healthcare.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Rami Fayed, Vice President and General Manager of Canada at AbbVie, gives insights into patient support programs in Canada, diversifying therapeutic pipelines, and giving back to the community.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Jaclyn Katelnikof, Saskatchewan-based Pharmacist, gives insights into the patient-facing role of the pharmacist, the need for tech innovations in pharmacy, and the threats to the Canadian drug supply.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Milva D’Aronco, Founding Member at Women Leaders in Pharma, gives insights into the importance of mentorship, coaching women on confidence, and diversity as a profit-driver in the long term.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Stephanie Veyrun-Manetti, General Manager of Specialty Care and Country Lead for Canada at Sanofi, gives insights into Sanofi’s Biogenius grants, the importance of DEI in Canada, and career development across all generations of employees.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Raj Dam, Assistant Director of Partnerships and External Relations at the University of Toronto, gives insights into co-op programs at University of Toronto’s Scarborough Campus, preparing students for the workplace and fostering partnerships with industry.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Corinne Buchanan-Russell, Co-founder of Advancing Black Talent in Pharma, gives insights into the responsibility of leaders to foster diversity, the perils of academic streaming, employee resource groups, and more.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Andrea Schwarz, Commercial Lead in Canada at BeiGene Canada, gives insights into launching a commercial team during the pandemic, being at a company that focuses solely on oncology, and providing opportunities for the next generation of pharma.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Dimitris Polygenis, President of Biopharma and Payer Solutions at McKesson Canada, gives insights using technology and AI to decrease prescribing and distribution times, virtual and real-time care, and targeted gene therapies.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Jennifer Wellman, Senior Marketing Manager of Emergent Biosolutions, gives insights into going from biochemistry to business and marketing, the benefits of cross training, and balancing volunteer commitments with career.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Dave Cann, Senior Director of Business Development of Inizio Engage, gives insights into the ‘new beginning’ for Ashfield, harnessing the entrepreneurial spirit in leadership roles, and adapting to change in your career.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Fanny Sie, Head of AI and Emerging Technology, External Collaboration, M&A Partnering of Roche Global Informatics, gives insights into going from clinician researcher to business school, cross-company collaboration on data sharing during the pandemic, and using AI data points for better diagnoses.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Kevin Leshuk, President and CEO of Forus Therapeutics, gives insights into advancing blood cancer therapeutics in Canada, managing your own career, and pivoting with change.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Paul Petrelli, General Manager of Jazz Pharmaceuticals, gives insights into workplace values of Generations X, Y, and Z, post-Covid leadership and work culture, and corporate responsibility.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Bonnie Crombie, Mayor of Mississauga, Ontario, give insights into the second largest life sciences sector in Canada, biotech programs at University of Toronto Mississauga, and balancing economic development with environmental sustainability.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Shanil Ebrahim, Partner and National Life Sciences and Healthcare Consulting Leader at Deloitte Canada, discusses improving healthcare literacy, expanding the use and integration of healthcare data, and public-private collaborations promoting equity in healthcare.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Ben Parry and Sylvia Pilon, Directors at Pangaea Group, discuss the evolution of customer-facing roles, overcoming silos in integrated health, and onboarding new talent in virtual workplaces.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Frank Stramaglia, GM of Astellas Pharma Canada Inc., discusses embracing technology and omni-channel marketing, employee engagement as a priority, and making compliance a company-wide responsibility.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Wendy Adams, GM of Galderma Canada Inc., discusses diversifying treatment portfolios, raising funds for kids with skin conditions, and encouraging collaboration with in-person meetings.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Justin Bates, CEO of the Ontario Pharmaceutical Association, discusses starting his position just before Covid, shifting pharmacies to a service model, and alternative payment models to National Pharmacare.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Brian Bloom, CEO of Bloom Burton & Co., discusses the Canadian investing landscape for pharma companies, tech trends in the healthcare industry, and expectations for the upcoming Bloom Burton Award Gala.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Ann Gomez, President and Founder of Clear Concept Inc., offers insights into work-life balance, maximizing productivity, and the value of routines.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Brigitte Nolet, President and CEO of Roche Canada, talks about empathetic leadership, precision medicine, and workplace culture.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Anastasia Lit, Co-founder of TechPharus, talks about using AI to enhance medical care and research, the rapid development of software and AI technologies, and how AI is transforming the labour market.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Pamela Fralick, President of Innovative Medicines Canada, talks about innovative funding models, working with all levels of the Canadian government, and developing the life sciences sector.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Eileen McMahon, Chair of Intellectual Property and Food and Drug Regulatory practices at Torys LLP, talks about strategic budgeting, the value of intellectual property rights, and reflecting on your personal and professional journey.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Tamer Yacoub Hanna, Multi-Channel Engagement Manager at AbbVie, talks about utilizing your unique experiences to develop your career, ensuring the ethical use of new technologies, and extending patient support beyond finances.
Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe
Dr. Kwadwo Kyeremanteng, Department Head of the Critical Care Unit at the Ottawa Hospital, talks about the value of implementing new technologies, experiencing racism in the healthcare system, and the importance of prioritizing love and compassion.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Karl Frank, Managing Director at Bayshore HealthCare, talks about empowering leaders in the workforce, maintaining community in a digital culture, and the value of continuing education.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Arnaud Lavenue, Senior Partner at Toc Toc Communications, talks about overcoming challenges, combining your passions through education, and being inducted into the Canadian Healthcare Marketing Hall of Fame.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Danielle Portnik, Regional Business Director, International at Ambry Genetics, talks about genetics and personalized medicine, building community, and moving the bar in healthcare.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Angelina Brathwaite, Senior Client Partner, Diversity, Inclusion and Belonging Leader for the Americas at Brunel, talks about women leadership in the pharma industry, community advocacy, and the true takeaways of formal education.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Carol Stiff, General Manager of Rhythm Pharmaceuticals Canada, talks about creating an inclusive company culture, small gestures of inclusion in the workplace, and being inducted into the Canadian Healthcare Marketing Hall of Fame.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Zal Press, Founder and Executive Director of Patient Commando, talks about patient representation, the empowerment of patients through virtual tools, and diversity and equity in health technology.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Mark Smithyes, President of Janus Life Sciences Consulting, talks about balancing in-person meetings with virtual calls, how a background in political science helps in pharma, and his volunteer work for non-profits.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Ross Glover, General Manager of Taiho Pharma Canada, talks about launching a drug during Covid, whether a science or business degree is best for entering pharma, and the clinical applications of AI in the life sciences.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
This episode reviews interviews with panelists in the upcoming 16th Annual National Pharmaceutical Congress on November 2nd, 2022. Hear valuable insights from Bob McLay of Sobi Canada, Janine Pajot of Bayer Canada, Pat Forsythe of Eisai Inc., and David Renwick of Emergent Biosolutions.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Dr. Greg Patey, CEO of Blue Charm Adherence Inc., talks about patient adherence programs, helping patients access medicine, and IT startups in Atlantic Canada.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Perry McLean, Head of Operational Excellence at GSK, talks about GSK’s new Canadian headquarters, embracing a hybrid working model, and the importance of emotional intelligence in the digital workplace.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Michael Stone, General Manager for Canada of Mallinckrodt Pharmaceuticals, talks about taking on a leadership role during the pandemic, attracting younger, tech-savvy talent and the relevance of an education degree in pharma.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Steve Saviuk, CEO of Valeo Pharma, talks about returning to in-person workplace interactions, family roots influencing company culture and standing out in the respiratory therapy market.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Jody Engel, Canada Country Lead at Knight Therapeutics, talks about company cultures, women leadership in pharma and attracting talent during the pandemic and retaining it.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
James Cran, Founder and CEO of Pharma Consultants Inc., talks about the evolution of pharma marketing, the consumerization of healthcare and leading by example in virtual workplaces.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Jim Hall, Senior Vice President and General Manager at Covis Pharma, talks about teaching online classes, keeping employees focused during the pandemic and learning leadership skills from mentors.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Angelique Berg, President and CEO of the Canadian Association for Pharmacy Distribution Management, talks about advancing technology, sharing data among stakeholder groups and managing supply chain disruptions.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Joan Chypyha, Founder and CEO of Alto Pharmaceuticals, talks about her career journey in pharma, the agility of a small pharma company and life lessons from mentors.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Brian Bloom, CEO of Bloom Burton & Co., talks about the digitization of healthcare, drawing venture capital to Canada, and the annual Bloom Burton conference.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Pat Forsythe, General Manager of Eisai Inc., talks about virtual work practices, the importance of real world evidence, and learning from differing workplace cultures in pharma.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
David Renwick, General Manager of Emergent Biosolutions, talks about how his time as a consultant affected his career journey, how the pandemic changed the office, and dealing with Covid-19 alongside the opioid crisis.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Michel Lavoie, President of Dermtek Pharma, talks about growing up and into the family business, the pandemic’s affect on therapeutic skin care products, and keeping up with clients in an increasingly virtual world.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Sandra Heller, General Manager of Seagen Canada, talks about taking on the role of GM at the beginning of a pandemic, the culture of oncology, and taking advantage of unexpected learning opportunities.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Cathy Harley, CEO of (Nurses Specialized in Wound, Ostomy and Continence) NSWOC, talks about social determinants of health, diversity in healthcare, and patient and public education.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Danny Goldman, Head of Strategy and Portfolio Operations of Sanofi Genzyme Canada, talks about his unique perspective to the patient journey, the need for cancer patient mentorship and adapting to virtual work practices.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Dr. Ted Witek of the Dalla Lana School of Public Health at the University of Toronto talks about his career journey from scientist to senior management, balancing academia and industry, and the integration of technology into health systems, with co-hosts Mitch Shannon, Jim Shea and Mark McElwain, in the second episode of our sixth season.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
The Co-Chair of Canada’s Vaccine Task Force, Mark Lievonen, talks about the vaccine rollout in Canada, the role of booster shots and the federal government’s Biomanufacturing and Life Sciences Strategy, with co-hosts Mitch Shannon, Jim Shea and Mark McElwain, in the first episode of our sixth season.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the bonus episode of the NPC Podcast, guest host Tiana DiMichele talks with Ed Gudaitis, President & CEO of Acerus Pharma, and Janine Pajot, VP Human Resources of Bayer, about present challenges facing pharma leaders, leading with authenticity, and creating a culture of leadership in the workplace.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the eighth and final episode of our fifth season, our host Peter Brenders talks with Ken Chan, VP Admin at Brock University, about his time in the provincial vaccine secretariat, vaccine mandates and anti-vaxxer protests.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the seventh episode of our fifth season, our host Peter Brenders talks with Martine Elias, Executive Director of Myeloma Canada, about how the pandemic has affected cancer patients, delayed diagnoses and treatments for myeloma patients, and recommendations for improving patient access.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the sixth episode of our fifth season, our host Peter Brenders talks with Tracy Clinch, Founder & CEO of Masitek Instruments Inc., about her business beginnings as a startup, creating in-line sensors for glass vials in pharmaceutical production and how Covid-19 affected her business.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fifth episode of our fifth season, our host Peter Brenders talks with Dr. Jason Field, President & CEO of Life Sciences Ontario, about vaccine mandates in the Canadian workplace, post-pandemic investments in biomanufacturing, and the place of PMPRB in the pharma landscape.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fourth episode of our fifth season, our host Peter Brenders talks with Dr. Blake Pearson, founder of Greenly Health and Pearson Health, about emerging research on medical cannabis, medical coverage and access, and the need for more education about the endocannabinoid system.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the third episode of our fifth season, our host Peter Brenders talks with Brian Bloom, Chairman & CEO of Bloom Burton & Co., about the investment climate, hot sectors for healthcare investment and the future of biotech.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the second episode of our fifth season, our host Peter Brenders talks with Adrienne Blanchard, Founder of Blanchard Law, about the differences between US and Canadian healthcare laws, life sciences regulations, and rules around DTC advertising.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the first episode of our fifth season, our host Peter Brenders talks with Dr. Angela Genge, Executive Director of the Clinical Research Unit at the Montreal Neurological Institute, about CNS research, recruiting patients for rare disease trials and the effect of Covid-19 on clinical trials.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the eighth and final episode of our fourth season, our host Peter Brenders talks with Ronnie Miller, President and CEO of Roche Canada, about structural change and innovation in organizations, celebrating and learning from failure, and the post-Covid field rep and office environment.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the seventh episode of our fourth season, our host Peter Brenders talks with Dr. Len Walt, VP Medical at SSI Strategy, about the role of the medical science liaison, the relationship between medical affairs and physicians, and the united front of medical and commercial.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the sixth episode of our fourth season, our host Peter Brenders talks with Brigitte Sonier-Ferguson, Acting CEO of the Atlantic Cancer Research Institute, about industry and academic partnerships, sharing expertise to help develop diagnostics in health care systems, and the impact of research on clinical care.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fifth episode of our fourth season, our host Peter Brenders talks with Bob McLay, Vice President and General Manager of Sobi Canada, about developing and manufacturing innovative therapies for rare diseases, Canadian rare disease policy and Canada’s funding model for precision medicine.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fourth episode of our fourth season, our host Peter Brenders talks with Gordon McCauley, President and CEO of adMare BioInnovations in Vancouver, about building Canadian life sciences companies, scaling up existing companies, and training the next generation of business and scientific leaders.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the third episode of our fourth season, our host Peter Brenders talks with Myka Osinchuk, Managing Director of Western Management Consultants, about transitioning into consulting, working across different industries, and consulting during Covid-19.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the second episode of our fourth season, our host Peter Brenders talks with Brenda Irwin, Founder and Managing Partner of the Relentless Venture Fund, about venture capital and angel investing in the life sciences, disrupting the standard of care status quo, and preventive health venture funds.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the first episode of our fourth season, our host Peter Brenders talks with Josh Neiman, Senior Vice President and Chief Commercial Officer for North America and Europe for BeiGene Limited, about bringing oncology drugs to new countries, balancing patient reach and profitability, and Canada as a market for global pharma companies.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the eighth and final episode of our third season, Host Peter Brenders talks with Sheryl Groeneweg, Director General of the Manufacturing and Life Sciences Branch of Innovation, Science and Economic Development Canada, about the future of bio-manufacturing, the convergence of technologies in the life sciences industry and the effect of Covid-19 on innovation in the industry.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the seventh episode of our third season, Peter Brenders talks with Dr. Rachel Asiniwasis, about her dermatological work servicing rural and remote Indigenous communities, Canada’s first national Close the Gap Day and the Indigenous Skin Spectrum Summit.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the sixth episode of our third season, Peter Brenders talks with Paul Petrelli, General Manager of Jazz Pharmaceuticals, about creating value with physicians, reputation management, and the resiliency of the pharma industry.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fifth episode of our third season, Peter Brenders talks with Dr. Bettina Hamelin, President and CEO of Ontario Genomics, about Canada’s research environment, industry partnerships and funding during the pandemic.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fourth episode of our third season, Peter Brenders talks with Lindsay Williams, Vice President and Managing Director of Stryker Canada, about her past career in pharma, diversity and inclusiveness in the life sci industry, and the role of medtech during the pandemic.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the third episode of our third season, Peter Brenders talks with Suzanne McGurn, president and CEO of CADTH, about the ever-evolving role of evidence and pivoting in her role as the new president of CADTH during a pandemic.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the second episode of our third season, Peter Brenders talks with Jim Shea, General Manager of the Council for Continuing Pharmaceutical Education, about sales reps and the effect of Covid-19 on continuing education in the pharma industry.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the first episode of our third season, Peter Brenders talks with Dr. Karen Lee, President and CEO of Parkinson Canada, about the impact of Covid-19 on the health charitable sector and research funding.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the eighth and final episode of our second season, Host Peter Brenders talks with Mike Cloutier, founding partner of Accelera Canada, about the Canadian regulatory process, hybrid market access and opportunities for foreign-based pharma companies.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the seventh episode of our second season, Peter Brenders talks with Mark Lievonen, retired President of Sanofi Pasteur Canada, about manufacturing and distributing a Covid-19 vaccine in Canada.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the sixth episode of our second season, Peter Brenders, CEO of the New Brunswick Health Research Foundation, talks with Denis Hello, General Manager of Abbvie Canada, about the acquisition of Allergan during the pandemic and Canada’s unique healthcare landscape from an outside perspective.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fifth episode of our second season, Peter Brenders, Founder & President of Kontollo Health, talks with Kevin Leshuk, veteran Canadian Pharma Executive, about planning his "next career act" at the same time the pharma industry is considering what kind of future it will face.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the fourth episode of our second season, Peter Brenders, Founder & President of Kontollo Health, talks with Nicole Serena, Vice President of PSP Systems and Solutions at Waldron & Associates, about publishing a white paper on the effect of Covid-19 on patient support programs.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the third episode of our second season, Peter Brenders, Founder & President of Kontollo Health, talks with Marie Lamont, President of Inteliquet, about matching patients to clinical trials during the pandemic.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the second episode of our second season, Peter Brenders, Founder & President of Kontollo Health, talks with Sheila Frame, Vice President Commercial: Marketing, Market Access and Patient Services at Sandoz, about helping pharma colleagues and rethinking skill sets during Covid-19.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In the first episode of our second season, Peter Brenders, Founder & President of Kontollo Health, talks with Lisa Mullett, General Manager of Sunovion, about motivating teams and adapting to a virtual landscape.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In our eighth episode, Peter Brenders, Founder & President of Kontollo Health, talks with Nancy White, President and CEO of Inagene Diagnostics, about switching from pharma to a Health IT startup.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In our seventh episode, Peter Brenders, Founder & President of Kontollo Health, talks with Robin Hunter, General Manager of Mallinckrodt Pharmaceuticals, about supplying products for Covid patients in and outside of Canada during lockdown.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In our sixth episode, Peter Brenders, Founder & President of Kontollo Health, talks with Mike Egli, General Manager of Aspen Pharmacare Canada Inc., and Patrick Massad, Commissioner of the Pharmaceutical Advertising Advisory Board (PAAB), about digital marketing to doctors and direct to consumer (DTC) advertising in Canada.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In our fifth episode, Peter Brenders, Founder & President of Kontollo Health, talks with Christine Lennon, General Manager of Incyte Biosciences Canada, about starting companies and bringing products to Canada during a pandemic.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In our fourth episode, Peter Brenders, Founder & President of Kontollo Health, talks with Lee Ferreira, Canadian General Manager of Ferring Pharmaceuticals, about building and maintaining relationships in the digital age.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
In our third episode, Peter Brenders, Founder & President of Kontollo Health, talks with the president of Innovative Medicines Canada, Pamela Fralick, about Canada's innovations in the pharma industry.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Host Peter Brenders, Founder & CEO of Kontollo Health, interviews Dr. Shafiq Qaadri, family physician, parliamentarian, and novelist about physician and pharma relationships during Covid-19.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com
Host Peter Brenders, Founder & CEO of Kontollo Health, interviews Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders (CORD) about patient groups in the age of Covid-19.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit healthbiz.substack.com